| What organization runs or oversees the operation of the facility? |
| Ministry of Health |
11 |
10 |
|
10 / 11 |
| Non-governmental organization |
11 |
1 |
|
1 / 11 |
| What is the type of the facility? |
| Primary hospital |
11 |
0 |
|
0 / 11 |
| Secondary hospital |
11 |
1 |
|
1 / 11 |
| Tertiary hospital |
11 |
10 |
|
10 / 11 |
| Independent specialized facility |
11 |
2 |
|
2 / 11 |
| What specialties are available to patients with Lassa Fever in your facility? |
| Isolation unit & PEP |
11 |
11 |
|
11 / 11 |
| Intensive care beds |
11 |
9 |
|
9 / 11 |
| Mechanical ventilation |
11 |
7 |
|
7 / 11 |
| Staff trained in high dependency care |
11 |
5 |
|
5 / 11 |
| Renal dialysis |
11 |
11 |
|
11 / 11 |
| FBC |
11 |
10 |
|
10 / 11 |
| E/U/Cr |
11 |
10 |
|
10 / 11 |
| LFT |
11 |
10 |
|
10 / 11 |
| Clotting profile |
11 |
6 |
|
6 / 11 |
| Blood gas analysis |
11 |
5 |
|
5 / 11 |
| Test for cardiac and hyperinflammatory markers |
11 |
6 |
|
6 / 11 |
| PCR |
11 |
11 |
|
11 / 11 |
| Eliza |
11 |
3 |
|
3 / 11 |
| IgG |
11 |
4 |
|
4 / 11 |
| IgM |
11 |
4 |
|
4 / 11 |
| Antigen detection |
11 |
2 |
|
2 / 11 |
| Blood transfusion capability |
11 |
11 |
|
11 / 11 |
| Plasma and platelet transfusions |
11 |
5 |
|
5 / 11 |
| Pregnancy testing |
11 |
11 |
|
11 / 11 |
| EEG |
11 |
6 |
|
6 / 11 |
| ECG |
11 |
9 |
|
9 / 11 |
| High flow oxygen therapy |
11 |
8 |
|
8 / 11 |
| ICP monitoring for unconscious patients |
11 |
2 |
|
2 / 11 |
| Ultrasound |
11 |
10 |
|
10 / 11 |
| Xray |
11 |
5 |
|
5 / 11 |
| Audiometry |
11 |
6 |
|
6 / 11 |
| Haematological support |
11 |
10 |
|
10 / 11 |
| Neonatal support |
11 |
7 |
|
7 / 11 |
| Nutritional support |
11 |
9 |
|
9 / 11 |
| Psychological support |
11 |
11 |
|
11 / 11 |
| Were any of your research studies specifically focused on sub-groups? If so which sub-groups? (i.e., pediatrics, pregnant women, under 5 years and greater than 50 years? |
| Vaccine trials |
11 |
5 |
|
5 / 11 |
| Drug therapy studies |
11 |
7 |
|
7 / 11 |
| Observational studies |
11 |
10 |
|
10 / 11 |
| Patient management studies |
11 |
6 |
|
6 / 11 |
| Education/training studies (e.g., education/training for healthcare workers, education/information for patients or caregivers) |
11 |
6 |
|
6 / 11 |
| Qualitative analysis (e.g., patient experiences, healthcare worker experiences.) |
11 |
5 |
|
5 / 11 |
| Host/animal interface |
11 |
5 |
|
5 / 11 |
| Quality of care (performance indicators) |
11 |
3 |
|
3 / 11 |
| Education/training studies (e.g., education/training for healthcare workers, education/information for patients or caregivers,) |
11 |
4 |
|
4 / 11 |
| Non-clinical quantitative analysis (e.g., health system outcomes) |
11 |
2 |
|
2 / 11 |
| Were/are any of your research studies specifically focused on sub-groups? If so which sub-groups? (i.e., pediatrics, pregnant women, children between 5 – 18 years and older adults? |
| Pregnant women |
11 |
6 |
|
6 / 11 |
| Children between 5-18 years old |
11 |
6 |
|
6 / 11 |
| Individuals older than 60 years old |
11 |
1 |
|
1 / 11 |
| Immunosuppressed |
11 |
1 |
|
1 / 11 |
| Please choose the study categories that are most related to the studies conducted by the facility: |
| Drug therapy studies (e.g., drug therapy for Lassa Fever.) |
11 |
8 |
|
8 / 11 |
| Patient management studies |
11 |
8 |
|
8 / 11 |
| Quality of care (performance indicators) |
11 |
4 |
|
4 / 11 |
| Vaccine trials |
11 |
5 |
|
5 / 11 |
| Education/training studies (e.g., education/training for healthcare workers, education/information for patients or caregivers,..) |
11 |
6 |
|
6 / 11 |
| Non-clinical quantitative analysis (e.g., health system outcomes) |
11 |
2 |
|
2 / 11 |
| Qualitative analysis (e.g., patient experiences, community perception, healthcare worker experiences,..) |
11 |
7 |
|
7 / 11 |
| Reservoir – host interface |
11 |
4 |
|
4 / 11 |
| Please choose ALL clinical areas that your research consortium collects information on: |
| Post Lassa Fever complications |
11 |
8 |
|
8 / 11 |
| Sensory Hearing Loss |
11 |
6 |
|
6 / 11 |
| Viral persistence |
11 |
5 |
|
5 / 11 |
| Obstetrics |
11 |
9 |
|
9 / 11 |
| Viral lineages |
11 |
3 |
|
3 / 11 |
| Sepsis |
11 |
7 |
|
7 / 11 |
| Neurological |
11 |
9 |
|
9 / 11 |
| Hematology |
11 |
7 |
|
7 / 11 |
| Cardiovascular |
11 |
8 |
|
8 / 11 |
| Renal |
11 |
9 |
|
9 / 11 |
| Coagulopathy |
11 |
6 |
|
6 / 11 |
| Endothelial |
11 |
3 |
|
3 / 11 |
| Psychiatry |
11 |
5 |
|
5 / 11 |
| Neonatal |
11 |
2 |
|
2 / 11 |
| Vaccination |
11 |
3 |
|
3 / 11 |
| What research training has been completed in your facility? |
| Staff trained in research, ethics, compliance and safety training (CITI Program) |
11 |
11 |
|
11 / 11 |
| Staff trained in “Good Clinical Laboratory Practice” (GCLP). |
11 |
11 |
|
11 / 11 |
| Training on how to store biological samples (i.e., blood, plasma, urine, sputum). |
11 |
10 |
|
10 / 11 |